Last reviewed · How we verify
NCT05400018
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
trial in GIST in 1,041 participants. Completed in 25 February 2021.
25 February 2021
Quick facts
| Lead sponsor | Genetron Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,041 |
| Start date | 20 November 2020 |
| Primary completion | 25 February 2021 |
| Estimated completion | 25 February 2021 |
| Sites | 3 locations across China |
Conditions studied
- GIST — all drugs for GIST →
- Gastrointestinal Stromal Tumors — all drugs for Gastrointestinal Stromal Tumors →
Sponsor
Genetron Health
Who can join
Eligibility, any sex, with GIST or Gastrointestinal Stromal Tumors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this trail is to evaluate the performance of Genetron D842V PCR kit in GIST patients using real-time PCR method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05400018
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for GIST
Currently open trials in the same condition.
- NCT07096609 — Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients · Phase 1, PHASE2 · recruiting
- NCT07411118 — RCT of EFTR Versus STER for GIST Treatment · NA · recruiting
- NCT06640361 — A Study of Olverembatinib in SDH-deficient GIST. · Phase 3 · recruiting
- NCT05804331 — The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study · recruiting
- NCT03050268 — Familial Investigations of Childhood Cancer Predisposition · recruiting
Other Genetron Health trials
Trials by the same sponsor.
- NCT05494853 — Novel Biomarker Assay for Biomarker Assay for HCC Detection · unknown
- NCT05395429 — Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients · unknown
- NCT05343832 — Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients · unknown
- NCT05023746 — Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients · completed
- NCT05100602 — Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05400018 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Genetron Health
- Last refreshed: 6 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05400018.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing